Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

NEOGAP Therapeutics

Request full access

Imagine if cancer patients who lack efficient treatment options could be cured

Stockholm, SwedenFounded 2016Biotech & Life Sciences

About NEOGAP Therapeutics

Developer of personalized cancer immunotherapy designed to precisely target and eliminate cancer. The company's product identifies optimal neoantigens to target, activate and multiply T-lymphocytes with the purpose of eradicating cancer, enabling cancer patients to recover from the disease.

Source: Dealroom company data

At a glance

Status
Operational
Employees
26
Open positions
None listed
Dealroom signal
60.8/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Oncology, Drug Development, EIC, Biotech and Pharma, Hard Tech, Horizon Europe, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Investment activity
1 company, latest Jun 2023
Capital deployed
—
Preferred round
ACQUISITION

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCOther financing Feb 2026 $11M $42M Sciety ↗
GRANTOther financing Mar 2024 $605K — Undisclosed ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

NEOGAP Therapeutics website traffic

Latest recorded traffic for NEOGAP Therapeutics is 590 monthly website visits, up 293.3% over the last three months. NEOGAP Therapeutics's team grew 0% over the past year.

Latest monthly visits590 3-month web change+293.3% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

NEOGAP Therapeutics in the Stockholm ecosystem

Live from Dealroom

The NEOGAP Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • European Innovation Council

Series A1 investor entered at this stage

  • Sciety
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See NEOGAP Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.